Ghallab Alotaibi

698 total citations
38 papers, 477 citations indexed

About

Ghallab Alotaibi is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Ghallab Alotaibi has authored 38 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Ghallab Alotaibi's work include Neuroscience and Neuropharmacology Research (4 papers), Medicinal Plants and Neuroprotection (3 papers) and Pain Mechanisms and Treatments (3 papers). Ghallab Alotaibi is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Medicinal Plants and Neuroprotection (3 papers) and Pain Mechanisms and Treatments (3 papers). Ghallab Alotaibi collaborates with scholars based in Saudi Arabia, Pakistan and Egypt. Ghallab Alotaibi's co-authors include Shafiqur Rahman, Tarapati Rana, Aayush Sehgal, Ahmed A. H. Abdellatif, Yosif Almoshari, Saurabh Bhatia, Muhammad Shahid Iqbal, Tapan Behl, Simona Bungău and Ahmed Al‐Harrasi and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Controlled Release and Molecules.

In The Last Decade

Ghallab Alotaibi

33 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghallab Alotaibi Saudi Arabia 11 185 49 44 43 40 38 477
Stanley Juan Chavéz Gutierrez Brazil 15 153 0.8× 43 0.9× 60 1.4× 43 1.0× 38 0.9× 45 606
Mohammed Alrouji Saudi Arabia 17 238 1.3× 129 2.6× 64 1.5× 29 0.7× 38 0.9× 58 720
Ihsan Ullah Pakistan 16 283 1.5× 100 2.0× 66 1.5× 41 1.0× 34 0.8× 44 685
Xiaxia Du China 14 287 1.6× 80 1.6× 39 0.9× 24 0.6× 19 0.5× 27 677
Saptadip Samanta India 15 212 1.1× 77 1.6× 51 1.2× 35 0.8× 26 0.7× 37 652
Mingsan Miao China 12 225 1.2× 43 0.9× 68 1.5× 30 0.7× 20 0.5× 101 722
Mallikarjuna Rao Gedda India 12 188 1.0× 35 0.7× 31 0.7× 13 0.3× 42 1.1× 22 728
Mohamed F. Hamed Egypt 15 178 1.0× 60 1.2× 36 0.8× 22 0.5× 55 1.4× 40 626
Sushil Chandra Regmi South Korea 13 369 2.0× 50 1.0× 51 1.2× 25 0.6× 24 0.6× 18 709
Fatemeh Norouzi Iran 13 110 0.6× 20 0.4× 26 0.6× 58 1.3× 25 0.6× 35 425

Countries citing papers authored by Ghallab Alotaibi

Since Specialization
Citations

This map shows the geographic impact of Ghallab Alotaibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghallab Alotaibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghallab Alotaibi more than expected).

Fields of papers citing papers by Ghallab Alotaibi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghallab Alotaibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghallab Alotaibi. The network helps show where Ghallab Alotaibi may publish in the future.

Co-authorship network of co-authors of Ghallab Alotaibi

This figure shows the co-authorship network connecting the top 25 collaborators of Ghallab Alotaibi. A scholar is included among the top collaborators of Ghallab Alotaibi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghallab Alotaibi. Ghallab Alotaibi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alotaibi, Ghallab, et al.. (2025). Pharmacological landscape of endoplasmic reticulum stress: Uncovering therapeutic avenues for metabolic diseases. European Journal of Pharmacology. 998. 177509–177509. 5 indexed citations
2.
Alotaibi, Ghallab, et al.. (2025). Glutamate transporter activator LDN-212320 prevents chronic pain-induced cognitive impairment and anxiety-like behaviors in a mouse model. Behavioural Brain Research. 482. 115440–115440. 3 indexed citations
3.
4.
Alharthi, Sitah, Ghallab Alotaibi, Aun Raza, et al.. (2024). Enhancing the therapeutic landscape of cutaneous leishmaniasis: pegylated liposomal delivery of miltefosine for controlled release and improved efficacy. Journal of Drug Delivery Science and Technology. 96. 105735–105735. 6 indexed citations
5.
Alotaibi, Ghallab. (2024). Prevalence, pandemic, preventions and policies to overcome antimicrobial resistance. Saudi Journal of Biological Sciences. 31(8). 104032–104032. 1 indexed citations
6.
Iqbal, Arshad, et al.. (2024). Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker). BMC Complementary Medicine and Therapies. 24(1). 12–12. 2 indexed citations
7.
Alotaibi, Ghallab, et al.. (2023). Glial Glutamate Transporter Modulation Prevents Development of Complete Freund’s Adjuvant-Induced Hyperalgesia and Allodynia in Mice. Brain Sciences. 13(5). 807–807. 7 indexed citations
8.
Alotaibi, Ghallab, Sitah Alharthi, Biswajit Basu, et al.. (2023). Nano-Gels: Recent Advancement in Fabrication Methods for Mitigation of Skin Cancer. Gels. 9(4). 331–331. 23 indexed citations
9.
10.
11.
Shinu, Pottathil, Anroop B. Nair, Katharigatta N. Venugopala, et al.. (2022). Progress Report: Antimicrobial Drug Discovery in the Resistance Era. Pharmaceuticals. 15(4). 413–413. 29 indexed citations
12.
Milella, Luigi, et al.. (2022). Oxyria digyna: A review on the nutritional value, phytochemistry and ethnopharmacology. 2–16. 2 indexed citations
13.
Hassan, Mohammed H., et al.. (2022). Serum Levels of Growth-Associated Protein-43 and Neurotrophin-3 in Childhood Epilepsy and Their Relation to Zinc Levels. Biological Trace Element Research. 201(2). 689–697. 3 indexed citations
14.
Alotaibi, Ghallab, Kanwal Khan, Saeed Ahmad Khan, et al.. (2022). Pan genome based reverse vaccinology approach to explore Enterococcus faecium (VRE) strains for identification of novel multi-epitopes vaccine candidate. Immunobiology. 227(3). 152221–152221. 15 indexed citations
15.
Jalal, Khurshid, Kanwal Khan, Ghallab Alotaibi, et al.. (2022). Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase. Molecular Diversity. 27(2). 793–810. 11 indexed citations
16.
Basharat, Zarrin, Kanwal Khan, Khurshid Jalal, et al.. (2022). An in silico hierarchal approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri. Infection Genetics and Evolution. 98. 105233–105233. 10 indexed citations
17.
Hussain, Yaseen, Haroon Khan, Ghallab Alotaibi, et al.. (2022). How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions. Molecules. 27(13). 4058–4058. 26 indexed citations
18.
Hussain, Abid, Haiyin Yang, Jun Zhang, et al.. (2022). mRNA vaccines for COVID-19 and diverse diseases. Journal of Controlled Release. 345. 314–333. 81 indexed citations
19.
Basharat, Zarrin, Kanwal Khan, Ghallab Alotaibi, et al.. (2021). Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening. Computers in Biology and Medicine. 141. 105165–105165. 20 indexed citations
20.
Behl, Tapan, Tarapati Rana, Ghallab Alotaibi, et al.. (2021). Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression. Biomedicine & Pharmacotherapy. 146. 112545–112545. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley Juan Chavéz Gutierrez Breakdown of academic impact, for papers by Mohammed Alrouji Breakdown of academic impact, for papers by Ihsan Ullah Breakdown of academic impact, for papers by Xiaxia Du Breakdown of academic impact, for papers by Saptadip Samanta Breakdown of academic impact, for papers by Mingsan Miao Breakdown of academic impact, for papers by Mallikarjuna Rao Gedda Breakdown of academic impact, for papers by Mohamed F. Hamed Breakdown of academic impact, for papers by Sushil Chandra Regmi Breakdown of academic impact, for papers by Fatemeh Norouzi
Rankless by CCL
2026